Stryker Hip Lawsuits Move Forward in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous Stryker hip recall clients who have filed claims in the New Jersey proceeding.

Free Case Review
Our Firm is representing a number of Stryker hip recall clients in this litigation, and we are pleased to see it moving forward. We look forward to continued progress in the coming months.

Hundreds of Stryker hip lawsuits (
that allege injuries due to Rejuvenate and ABG II Modular-Neck Hip Stems continue to move forward in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on May 20, 2014, all 12 Stryker hip recall claims selected for Phase I and II of the proceeding’s Early Mediation Program have completed the process and have been resolved. Additional Stryker hip lawsuits are slated to go through the mediation process over the next 30 days. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

“Our Firm is representing a number of Stryker hip recall clients in this litigation, and we are pleased to see it moving forward. We look forward to continued progress in the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered debilitating complications allegedly related to the Stryker hip recall for Rejuvenate and ABG II hip stems.

Stryker Hip Recall
According to court documents, more than 20,000 Rejuvenate and ABG II hip stems were sold worldwide prior to the announcement of the Stryker hip recall in July 2012. The recall was announced after post-market data indicated the metal-components were subject to a high rate of corrosion and fretting at the modular-neck hip stems. Among other things, Stryker has urged all Rejuvenate and ABG II patients to undergo medical imaging, as well as blood tests for elevated metal ion levels, to ensure their artificial hips are performing as intended.*

Court records indicate that at least 1,220 Stryker hip lawsuits are now pending in the litigation underway in New Jersey. All of these lawsuits similarly allege that fretting and corrosion of the Stryker hip stems can result in painful and often permanent injuries, including metallosis, tissue necrosis, osteolysis, and premature device failure.
In addition to the Stryker hip recall claims that have been filed in New Jersey, court documents indicate that more than 800 additional lawsuits are pending in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. According to court records, 14 Stryker hip lawsuits filed in that proceeding have been resolved through mediation. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Individuals who have allegedly suffered serious complications related to the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website